Sales by Region and Category Regional and product category sales performance for 2010 compared to 2009, in reported dollars and local currency, was as follows:
## Table 0 ##
Local Currency Sales Drivers North America Fine & Beauty sales growth was driven by 16% growth in Fine Fragrance associated with general demand recovery (including some elements of re-stocking) as well as weaker year ago comparison levels (mostly in the first half of the year) combined with good market success for new business launches.
The strong performance in Ingredients reflects broad-based volume gains, re-stocking and weak market conditions last year.
Functional Fragrance sales increased as strong new business wins across all categories more than offset volume erosion in Fabric Care, with the strongest gain within the Home Care category.
Double-digit growth in Beverages (volume) and Confectionery (net new wins) categories led the growth in the Flavors business, with Savory also contributing solid growth.  ?
EAME delivered strong sales gains across all categories (except Personal Wash), led by new business and demand recovery in Fine Fragrance, Ingredients and Fabric Care plus net new wins and higher volume for Flavors, notably within the Beverage category, which grew 27%.
The Flavors business also benefited from double-digit growth in Confectionery and Dairy.
Re-stocking also supported growth in the developed countries within the region across most categories.  ?
Latin America’s sales performance was led by general recovery in demand and new business in Fine Fragrance, which grew 50%.
Double-digit growth in Beauty Care, Confectionery, Dairy and Savory categories more than offset the effect of nonstrategic Flavors’ business lost last year.
The Functional Fragrance category improvement benefited from both new business and volume recovery in Home Care and Fabric Care.  ?
Greater Asia delivered double-digit LC sales growth in all categories.
Fine & Beauty Care gains were driven by demand recovery and new business wins in Hair Care and Toiletries.
Fine Fragrance’s growth of 40% also benefited from demand recovery and a weaker prior year base.
Within Functional Fragrances, Fabric, Home Care and Personal Wash all achieved double-digit gains reflecting both strong commercial performance and solid demand growth.
Flavor sales growth was driven by new product introductions and volume growth mainly in Savory, Beverage and Confectionery, with all major categories producing double-digit gains 2009 in Comparison to 2008 Sales for 2009 totaled $2,326 million, decreasing 3% from the prior year period of $2,389 million, as Flavor sales declined 1% and Fragrance sales decreased 4%.
Foreign exchange had a 3% negative impact on reported sales during 2009 as the U. S.  dollar was stronger during the first three-quarters of 2009 versus the comparable year-ago period.
Market conditions improved during the second half of 2009, as global economic conditions strengthened and customer inventory levels stabilized.
LC sales increased over 2% during both the third and fourth quarters compared to a decline of 3% during the first six months of 2009.
repurchased under the program as of December 31, 2015.
The purchases will be made from time to time on the open market or through private transactions as market and business conditions warrant.
Repurchased shares will be placed into treasury stock.
The ultimate level of purchases will be a function of the daily purchase limits established in the pre-approved program according to the share price at that time.
This plan expires on December 31, 2017.
NOTE 12.
STOCK COMPENSATION PLANS The Company has various equity plans under which its officers, senior management, other key employees and directors may be granted options to purchase IFF common stock or other forms of stock-based awards.
Beginning in 2004, the Company granted Restricted Stock Units (“RSUs”) as the principal element of its equity compensation for all eligible U. S.  based employees and a majority of eligible overseas employees.
Vesting of the RSUs is solely time based; the vesting period is primarily 3 years from date of grant.
For a small group of employees, primarily overseas, the Company granted stock options prior to 2008.
The cost of all employee stock-based awards are principally recognized on a straight-line attribution basis over their respective vesting periods, net of estimated forfeitures.
Total stock-based compensation expense included in our Consolidated Statement of Income and Comprehensive Income was as follows:
## Table 1 ##
The shareholders of the Company approved the Company’s 2015 Stock Award and Incentive Plan (the “2015 Plan”) at the Annual Meeting of Shareholders held on May 6, 2015.
The 2015 Plan replaced the Company’s 2010 Stock Award and Incentive Plan (the “2010 Plan”) and provides the source for future deferrals of cash into deferred stock under the Company’s Deferred Compensation Plan (with the Deferred Compensation Plan being deemed a subplan under the 2010 Plan for the sole purpose of funding deferrals under the IFF Share Fund).
Under the 2015 Plan, a total of 1,500,000 shares are authorized for issuance, including 1,552,694 shares remaining available under a previous plan that was rolled into the 2015 Plan.
At December 31, 2015, 1,047,759 shares were subject to outstanding awards and 2,777,127 shares remained available for future awards under all of the Company’s equity award plans, including the 2015 Plan (excluding shares not yet issued under open cycles of the Company’s Long-Term Incentive Plan).
The Company offers a Long-Term Incentive Plan (“LTIP”) for senior management.
The targeted payout is 50% cash and 50% IFF stock at the end of the three-year cycle and provides for segmentation in which onefourth of the award vests during each twelve-month period, with the final one-fourth segment vesting over the full three-year period.
The 2011 grant was earned based on the achievement of defined EPS targets and our performance ranking of total shareholder return as a percentile of the S&P 500.
Commencing with the 2012-2014 LTIP cycle, the Company used Economic Profit (“EP”), rather than EPS, as one of the two financial metrics of Company performance.
EP measures operating profitability after considering (i) all our operating costs, (ii) income taxes and (iii) a charge for the capital employed in the business.
When the award is granted, 50% of the target dollar value of the award is converted to a number of “notional” shares based on the closing price at the beginning of the cycle.
For those shares whose payout is based on shareholder return as a percentile of the S&P 500, compensation expense is recognized using a graded-vesting attribution method, while compensation expense for the remainder of the performance shares (e. g. , EPS targets) is recognized on a straight-line basis over the vesting period based on the probable outcome of the performance condition.
NOTE 11.
SHAREHOLDERS’ EQUITY Dividends Cash dividends declared per share were $2.40, $2.06 and $1.72 in 2016, 2015 and 2014, respectively.
The Consolidated Balance Sheet reflects $50.7 million of dividends payable at December 31, 2016.
This amount relates to a cash dividend of $0.64 per share declared in December 2016 and paid in January 2017.
Dividends declared, but not paid as of December 31, 2015 and December 31, 2014 were $44.8 million ($0.56 per share) and $38.0 million ($0.47 per share), respectively.
Share Repurchases In December 2012, the Board of Directors authorized a $250 million share repurchase program, which commenced in the first quarter of 2013.
In August 2015, the Board of Directors approved an additional $250 million share repurchase authorization and extension through December 31, 2017.
Based on the total remaining amount of $109.3 million available under the repurchase program, approximately 0.9 million shares, or 1.2% of shares outstanding (based on the market price and shares outstanding as of December 31, 2016) could be repurchased under the program as of December 31, 2016.
During the year ended December 31, 2016, the Company repurchased 1.1 million shares on the open market at an aggregate cost of $127.4 million or an average of $120.45 per share.
The purchases will be made from time to time on the open market or through private transactions as market and business conditions warrant.
Repurchased shares will be placed into treasury stock.
The ultimate level of purchases will be a function of the daily purchase limits established in the pre-approved program according to the share price at that time.
This plan expires on December 31, 2017.
NOTE 12.
STOCK COMPENSATION PLANS The Company has various equity plans under which its officers, senior management, other key employees and Board of Directors may be granted options to purchase IFF common stock or other forms of stock-based awards.
Beginning in 2004, the Company granted Restricted Stock Units (“RSUs”) as the principal element of its equity compensation for all eligible U. S. -based employees and a majority of eligible overseas employees.
Vesting of the RSUs is solely time based; the vesting period is primarily 3 years from date of grant.
For a small group of employees, primarily overseas, the Company granted stock options prior to 2008.
The cost of all employee stock-based awards are principally recognized on a straight-line attribution basis over their respective vesting periods, net of estimated forfeitures.
Total stock-based compensation expense included in the Consolidated Statement of Income and Comprehensive Income was as follows:
## Table 2 ##
The shareholders of the Company approved the Company’s 2015 Stock Award and Incentive Plan (the “2015 Plan”) on May 6, 2015.
The 2015 Plan replaced the Company’s 2010 Stock Award and Incentive Plan (the “2010 Plan”) and provides the source for future deferrals of cash into deferred stock under the Company’s Deferred Compensation Plan (with the Deferred Compensation Plan being deemed a subplan under the 2015 Plan for the sole purpose of funding deferrals under the IFF Share Fund).
Under the 2015 Plan, a total of 1,500,000 shares are authorized for issuance in addition to 1,552,694 shares remaining available under the 2010 plan that were rolled into the 2015 Plan.
At December 31, 2016, 853,746 shares were subject to outstanding awards and 2,715,923 shares remained available for future awards under all of the Company’s equity award plans, including the 2015 Plan (excluding shares not yet issued under open cycles of the Company’s Long-Term Incentive Plan).

<table><tr><td></td><td></td><td colspan="6"> % Change in Sales — 2010 vs 2009</td><td></td></tr><tr><td></td><td></td><td>Fine & Beauty Care</td><td>Functional</td><td>Ingredients</td><td>Total Frag.</td><td>Flavors</td><td> Total</td><td></td></tr><tr><td> North America</td><td> Reported</td><td>11%</td><td>2%</td><td>23%</td><td>11%</td><td>6%</td><td> 8</td><td> %</td></tr><tr><td> EAME</td><td> Reported</td><td>25%</td><td>1%</td><td>12%</td><td>12%</td><td>10%</td><td> 11</td><td> %</td></tr><tr><td></td><td> <i>Local Currency</i></td><td>31%</td><td>6%</td><td>17%</td><td>17%</td><td>13%</td><td> <i>15</i></td><td> <i>%</i></td></tr><tr><td> Latin America</td><td> Reported</td><td>44%</td><td>5%</td><td>14%</td><td>20%</td><td>10%</td><td> 16</td><td> %</td></tr><tr><td></td><td> <i>Local Currency</i></td><td>40%</td><td>5%</td><td>14%</td><td>18%</td><td>6%</td><td> <i>14</i></td><td> <i>%</i></td></tr><tr><td> Greater Asia</td><td> Reported</td><td>22%</td><td>19%</td><td>11%</td><td>18%</td><td>17%</td><td> 18</td><td> %</td></tr><tr><td></td><td> <i>Local Currency</i></td><td>20%</td><td>17%</td><td>10%</td><td>17%</td><td>12%</td><td> <i>14</i></td><td> <i>%</i></td></tr><tr><td> Total</td><td> Reported</td><td>24%</td><td>6%</td><td>15%</td><td>14%</td><td>11%</td><td> 13</td><td> %</td></tr><tr><td></td><td> <i>Local Currency</i></td><td>26%</td><td>7%</td><td>18%</td><td>16%</td><td>10%</td><td> <i>13</i></td><td> <i>%</i></td></tr></table>
<table><tr><td></td><td colspan="3">December 31,</td></tr><tr><td>(DOLLARS IN THOUSANDS)</td><td>2015</td><td>2014</td><td>2013</td></tr><tr><td>Equity-based awards</td><td>$23,160</td><td>$22,648</td><td>$23,736</td></tr><tr><td>Liability-based awards</td><td>4,784</td><td>4,354</td><td>4,042</td></tr><tr><td>Total stock-based compensation</td><td>27,944</td><td>27,002</td><td>27,778</td></tr><tr><td>Less tax benefit</td><td>-8,348</td><td>-8,018</td><td>-8,456</td></tr><tr><td>Total stock-based compensation, net of tax</td><td>$19,596</td><td>$18,984</td><td>$19,322</td></tr></table>
<table><tr><td></td><td colspan="3">December 31,</td></tr><tr><td>(DOLLARS IN THOUSANDS)</td><td>2016</td><td>2015</td><td>2014</td></tr><tr><td>Equity-based awards</td><td>$24,587</td><td>$23,160</td><td>$22,648</td></tr><tr><td>Liability-based awards</td><td>3,884</td><td>4,784</td><td>4,354</td></tr><tr><td>Total stock-based compensation</td><td>28,471</td><td>27,944</td><td>27,002</td></tr><tr><td>Less tax benefit</td><td>-7,375</td><td>-8,348</td><td>-8,018</td></tr><tr><td>Total stock-based compensation, net of tax</td><td>$21,096</td><td>$19,596</td><td>$18,984</td></tr></table>

Question: In what year is Total Sales Reported for Fine & Beauty Care larger between 2009 and 2010?
Answer: 2010